Optimal medication for tumors modeled by a Cahn-Hilliard-Brinkman equation

From MaRDI portal
Publication:2002008

DOI10.1007/S00526-019-1579-ZzbMATH Open1418.35246arXiv1811.07783OpenAlexW2963464761WikidataQ115387161 ScholiaQ115387161MaRDI QIDQ2002008FDOQ2002008


Authors: Matthias Ebenbeck, Patrik Knopf Edit this on Wikidata


Publication date: 11 July 2019

Published in: Calculus of Variations and Partial Differential Equations (Search for Journal in Brave)

Abstract: In this paper, we study a distributed optimal control problem for a diffuse interface model for tumor growth. The model consists of a Cahn-Hilliard type equation for the phase field variable coupled to a reaction diffusion equation for the nutrient and a Brinkman type equation for the velocity. The system is equipped with homogeneous Neumann boundary conditions for the tumor variable and the chemical potential, Robin boundary conditions for the nutrient and a "no-friction" boundary condition for the velocity. The control acts as a medication by cytotoxic drugs and enters the phase field equation. The cost functional is of standard tracking type and is designed to track the variables of the state equation during the evolution and the distribution of tumor cells at some fixed final time. We prove that the model satisfies the basics for calculus of variations and we establish first-order necessary optimality conditions for the optimal control problem.


Full work available at URL: https://arxiv.org/abs/1811.07783




Recommendations



Cites Work


Cited In (28)





This page was built for publication: Optimal medication for tumors modeled by a Cahn-Hilliard-Brinkman equation

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q2002008)